Clozapine increases dopamine release in prefrontal cortex by 5-HT(1A) receptor activation

European Journal of Pharmacology

Volumn 338, Issue 2, 1997, Pages

  Rollema, Hans ^a   Lu, Yi ^a   Schmidt, Anne W ^a   Zorn, Stevin H ^a  

^a PFIZER INC   (United States)

Author keywords

Clozapine; Cortical DA release; Serotonin 5 HT(1A) receptor

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; CLOZAPINE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; NEUROLEPTIC AGENT; SEROTONIN 1A RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; DOPAMINE RELEASE; DRUG EFFECT; EXTRAPYRAMIDAL SYMPTOM; MALE; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030694503     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)81951-6     Document Type: Article

References (9)

1. Meltzer H.Y., Chai B.L., Thompson P.A., Yamamoto B.K. Effect of scopolamine on the efflux of dopamine and its metabolites after clozapine, haloperidol or thioridazine. J. Pharm. Exp. Ther. 268:1994;1452-1461.
2. Moghaddam B., Bunney B.S. Acute effects of typical and atypical antipsychotic drugs on the release of dopamine from the prefrontal cortex, nucleus accumbens and striatum of the rat: An in vivo microdialysis study. J. Neurochem. 54:1990;1755-1760.
3. 1A receptors. Neuropharmacology. 25:1996;119-121.
4. Santiago M., Machado A., Cano J. Regulation of prefrontal cortical dopamine release by dopamine receptor agonists and antagonists. Eur. J. Pharmacol. 239:1993;83-91.
5. Seeger T.F., Seymour P.A., Schmidt A.W., Zorn S.H., Schulz D.W., Lebel L.A., McLean S., Guanowski V., Howard H.R., Lowe J.A. III, Heym J. Ziprasidone (CP-88,059): A new antipsychotic with combined dopamine and serotonin receptor antagonist activity. J. Pharm. Exp. Ther. 275:1995;101-113.
6. Tandon R., Harrigan E., Zorn S. Ziprasidone: A novel antipsychotic with unique pharmacology and therapeutic potential. J. Serotonin Res. 4:1997;159-177.
7. 1A receptors in the rat prefrontal cortex. Eur. J. Pharmacol. 305:1996;73-78.
8. Weinberger D.R., Lipska B.K. Cortical maldevelopment, anti-psychotic drugs, and schizophrenia: A search for a common ground. Schizophr. Res. 16:1995;87-110.
9. 4 receptor agonist. Eur. J. Pharmacol. 269:1994;R1-R2.